CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Accounting Officer sold 3,630 shares at $0.92 ($3,355)
- 4 Open-market sale Chief Development Officer sold 16,748 shares at $0.92 ($15,479)
- 4 Open-market sale Chief Commercial Officer sold 17,527 shares at $0.92 ($16,198)
- 4 Open-market sale President & CEO sold 83,660 shares at $0.92 ($77,319)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 24,664 shares at $0.92 ($22,794)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 4 Open-market buy Director bought 100,000 shares at $1.23 ($122,840)
- 4 Open-market buy Director bought 35,000 shares at $1.16 ($40,562)
- 4 Open-market buy Director bought 200,000 shares at $1.17 ($234,000)
- 4 Open-market sale Chief Accounting Officer sold 203 shares at an average $1.40 ($283)
- 4 Open-market sale Chief Development Officer sold 427 shares at an average $1.40 ($596)
- 4 Open-market sale Chief Commercial Officer sold 462 shares at an average $1.40 ($645)
Page 7 of 31 · 602 filings